Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 24044228)

1.

Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.

Lee J.

Mod Healthc. 2013 Jul 15;43(28):8-9. No abstract available.

PMID:
24044228
2.

New drug for hepatitis C contributes to 13% rise in spending on prescription drugs in US.

McCarthy M.

BMJ. 2015 Apr 17;350:h2055. doi: 10.1136/bmj.h2055. No abstract available.

PMID:
25888306
3.

Medicare, Medicaid, and pharmaceuticals: the price of innovation.

Kevles DJ.

Yale J Health Policy Law Ethics. 2015 Winter;15(1):241-6. No abstract available.

PMID:
25876383
4.

Pharmaceuticals and medical devices: Medicare Part D.

Thomson Reuters Accelus, Steiner DJ.

Issue Brief Health Policy Track Serv. 2014 Dec 29:1-31. No abstract available.

PMID:
25771554
5.

Pharmaceuticals and medical devices: cost savings.

Thomson Reuters Accelus, Steiner DJ.

Issue Brief Health Policy Track Serv. 2014 Dec 29:1-32. No abstract available.

PMID:
25771553
6.

Not all discounts on certain cancer drugs have disappeared.

Thompson CA.

Am J Health Syst Pharm. 2015 Feb 15;72(4):259-60. doi: 10.2146/news150012. No abstract available.

PMID:
25631827
7.

What's at stake in effort to diminish 340B program.

Henkel B.

Mod Healthc. 2014 Sep 29;44(39):34. No abstract available.

PMID:
25509599
8.

US hospitals object to changes in Genentech drug distribution.

Furlow B.

Lancet Oncol. 2014 Dec;15(13):e591. doi: 10.1016/S1470-2045(14)71040-X. Epub 2014 Nov 7. No abstract available. Erratum in: Lancet Oncol. 2014 Dec;15(13):e587.

PMID:
25499290
9.

How to save big on Rx.

[No authors listed]

Consum Rep. 2014 Dec;79(12):20. No abstract available.

PMID:
25423686
10.

Two Americas. Hospitals see big differences between Medicaid expansion and nonexpansion states.

Kutscher B.

Mod Healthc. 2014 Aug 18;44(33):20-2. No abstract available.

PMID:
25318254
11.

HHS defends expanded 340B drug discounts.

Lee J.

Mod Healthc. 2014 Jun 16;44(24):9. No abstract available.

PMID:
25137989
12.

The impact of the Massachusetts health care reform on unpaid medical bills.

Arrieta A.

Inquiry. 2013 Aug;50(3):165-76. doi: 10.1177/0046958013516580.

PMID:
25117084
13.

Why Medicaid expansion won't swamp state budgets.

Goozner M.

Mod Healthc. 2014 Jun 9;44(23):24. No abstract available.

PMID:
25016885
14.

Physician-industry teamwork advances care.

Harbaugh RE.

Mod Healthc. 2014 Apr 21;44(16):25. No abstract available.

PMID:
24956723
15.

Regulation. Bill due for drugmakers' winning strategy.

Lee J.

Mod Healthc. 2014 Jun 2;44(22):10. No abstract available.

PMID:
24946373
16.

CMS retreats on Part D rule intended to reduce drug costs and improve access.

Dickson V.

Mod Healthc. 2014 Mar 17;44(11):10. No abstract available.

PMID:
24830094
17.

US citizens' use of healthcare services rises.

McCarthy M.

BMJ. 2014 Apr 17;348:g2841. doi: 10.1136/bmj.g2841. No abstract available.

PMID:
24742883
18.

The $500 million idea: how CMS can help us achieve better care at a lower cost.

Erich J.

EMS World. 2014 Mar;43(3):22-3. No abstract available.

PMID:
24738162
19.

Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.

American Society of Clinical Oncology.

J Oncol Pract. 2014 Jul;10(4):259-63. doi: 10.1200/JOP.2014.001432. Epub 2014 Apr 15. No abstract available.

20.

New government in Rajasthan is accused of trying to sabotage free drug scheme.

Sachan D.

BMJ. 2014 Apr 15;348:g2729. doi: 10.1136/bmj.g2729. No abstract available.

PMID:
24735955
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk